Non-acute kidney | Acute kidney injury | p-value | |
---|---|---|---|
injury (n=95) | (n=54) | ||
Male | 74(77.9%) | 41(75.9%) | 0.783 |
Female | 21(22.1%) | 13(24.1%) | |
Malay | 54(56.8%) | 26(48.1%) | |
Chinese | 19(20.9%) | 14(25.9%) | 0.859 |
Indian | 14(14.7%) | 9(16.7%) | |
Others | 8(8.4%) | 5(9.3%) | |
43.3(18.6) | 46.8(15.5) | ||
<40 | 45(47.4%) | 20(37.0%) | |
41-60 | 31(32.6%) | 22(40.7%) | 0.238 |
>61 | 19(20.0%) | 12(22.2%) | |
70[63-80] | 80[70-86.8] | ||
<50 | 10(10.5%) | 0 | <0.001* |
51-70 | 25(26.3%) | 12(22.5%) | |
>71 | 60(63.2%) | 42(77.8%) | |
Length of Stay in ICU (days) | 5[2-8] | 5[3-11.25] | 0.210 |
5.8(3.7) | 10.7(4.3) | ||
≤2 | 18(18.9%) | 2(3.7%) | <0.001* |
>2 | 77(81.1%) | 52(96.3%) | |
Diabetes | 17(17.9%) | 17(31.5%) | 0.057 |
Asthma | 7(7.4%) | 3(5.6%) | 0.748 |
Hypertension | 21(22.1%) | 19(35.2%) | 0.083 |
Creatinine kinase level on upon diagnosis of rhabdomyolysis | 2179[1246-4742] | 2065[796-7741] | 0.435 |
Creatinine kinase level post-treatment | 1578[661-2374] | 2030[764-5548] | 0.048* |
Time taken to reach the highest creatinine kinase (days) | 2[1-2] | 2[1-3] | 0.260 |
Mortality | 4(4.2%) | 19(35.2%) | <0.001* |
Risk factors | Non-acute kidney injury (n=95) | Acute kidney injury (n=54) | Odds raito | 95% CI |
p-value | |
---|---|---|---|---|---|---|
Lowe | Upper | |||||
Weight >50 kg | 1.040 | 1.016 | 1.064 | <0.001 |
||
SOFA score (>2) | 1.372 | 1.223 | 1.539 | <0.001 |
||
Antipsychotics | 2 (2.1%) | 1 (1.9%) | 0.702 | |||
Sepsis | 15 (15.8%) | 27 (50%) | 5.333 | 2.476 | 11.487 | <0.001 |
Prolonged Surgery | 17 (17.9%) | 8 (14.7%) | 0.658 | |||
Trauma | 46 (48.4%) | 17 (31.5%) | 0.489 | 0.243 | 0.987 | 0.046 |
Hyperthermia | 0 | 1 (1.9%) | 0.362 |
Variable | Odds raito | 95% CI |
p-value | |
---|---|---|---|---|
Lower | Upper | |||
Weight (>50 kg) | 1.034 | 1.006 | 1.063 | 0.016 |
Sofa Score (>2) | 1.299 | 1.151 | 1.467 | <0.001 |
Sepsis | 2.475 | 0.978 | 6.261 | <0.05 |